PRIA Logo™
HR7777119th CongressWALLET

Protecting America’s Medical Supply Chains Act of 2026

Sponsored By: Representative Salazar, Maria Elvira [R-FL-27]

Introduced

Summary

Securing U.S. medical supply chains. This bill would expand the Defense Production Act to prioritize medical materials and require a federal strategy to identify vulnerabilities, diversify suppliers, and use DPA tools to keep drugs, devices, and biologics available for national defense.

Show full summary
  • Manufacturers and domestic producers: Would let the President pay eligible U.S. entities to strengthen supply chains for critical components, products, or raw materials. Payments require a 30-day certification to Congress and entities must be organized under U.S. law.
  • Patients, clinicians, and public health systems: Would require a strategy that analyzes vulnerabilities for drugs, devices, and biological products and recommends steps to diversify sources and timelines to avoid essential supply elements falling under exclusive foreign control.
  • Federal agencies and Congress: Would require the President to deliver the strategy within 180 days in consultation with HHS, Commerce, Homeland Security, and Defense and to send annual progress reports. The bill also directs the administration to write rules within 90 days defining "supply chain" and "supply chain activities."

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

Payments to U.S. critical suppliers

If enacted, the bill would let the President make payments to U.S. companies to strengthen critical supply chains. The President would have to certify to Congress at least 30 days before any payment that it is critical to meet national defense needs. Only entities organized under U.S. law that produce critical components, critical technologies, products, or raw materials for supply chain security would be eligible. The President would have to publish rules defining "supply chain" and "supply chain activities" within 90 days of enactment.

Use DPA to secure medical supplies

If enacted, the bill would direct agencies to use the Defense Production Act when appropriate to keep needed medical materials available, including measures to secure the drug supply chain. It would amend law to say that "materials" include medical materials such as drugs, medical devices, and biological products used to diagnose, treat, or prevent disease. Agencies would be required to consider U.S. competitiveness, scientific leadership and cooperation, and innovation when using those authorities. This would make it easier for the government to prioritize or compel domestic production of essential medical items, though it does not itself provide specific funding amounts.

Sponsors & CoSponsors

Sponsor

Salazar, Maria Elvira [R-FL-27]

FL • R

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation